Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women
- 1 September 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 46 (3) , 500-507
- https://doi.org/10.1161/01.hyp.0000177437.07240.70
Abstract
Acetaminophen, ibuprofen, and aspirin are the most commonly used drugs in the United States. Although the frequency of their use has been associated with hypertension, prospective data examining the dose of these drugs and risk of hypertension are lacking. Furthermore, whether certain indications for analgesic use, particularly headache, mediate the association is unclear. We conducted 2 prospective cohort studies among older women 51 to 77 years of age (n=1903) from the Nurses’ Health Study I and younger women 34 to 53 years of age (n=3220) from the Nurses’ Health Study II who completed detailed supplemental questionnaires pertaining to their analgesic use and who did not have hypertension at baseline. We analyzed incident hypertension according to categories of average daily dose of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin. Information on indications for analgesic use as well as relevant confounders was also gathered prospectively. Compared with women who did not use acetaminophen, the multivariable adjusted relative risk for those who took >500 mg per day was 1.93 (1.30 to 2.88) among older women and 1.99 (1.39 to 2.85) among younger women. For nonsteroidal anti-inflammatory drugs, similar comparisons yielded multivariable relative risks of 1.78 (1.21 to 2.61) among older women and 1.60 (1.10 to 2.32) among younger women. These associations remained significant among women who did not report headache. Aspirin dose was not significantly associated with hypertension. Higher daily doses of acetaminophen and nonsteroidal anti-inflammatory drugs independently increase the risk of hypertension in women. Because acetaminophen and nonsteroidal anti-inflammatory drugs are commonly used, they may contribute to the high prevalence of hypertension in the United States.Keywords
This publication has 27 references indexed in Scilit:
- Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertensionJournal Of Hypertension, 2003
- How useful are unpublished data from the Food and Drug Administration in meta-analysis?Journal of Clinical Epidemiology, 2003
- Nonnarcotic Analgesic Use and the Risk of Hypertension in US WomenHypertension, 2002
- Renal Effects of COX-2-Selective InhibitorsAmerican Journal of Nephrology, 2001
- Endothelium-dependent vasorelaxation is inhibited byin vivodepletion of vascular thiol levels: Role of endothelial nitric oxide synthaseFree Radical Research, 2001
- N-Acetylcysteine Enhances Endothelium-Dependent Vasorelaxation in the Isolated Rat Mesenteric ArteryAnnals of Emergency Medicine, 1998
- NSAIDs and Blood PressureDrugs & Aging, 1998
- An Epidemiologic Study of Abuse of Analgesic DrugsNew England Journal of Medicine, 1991
- The clinical significance of inhibition of renal prostaglandin synthesisKidney International, 1987
- Effect of acetaminophen on prostaglandin E2 and prostaglandin F2α synthesis in the renal inner medulla of ratBiochimica et Biophysica Acta (BBA) - General Subjects, 1978